425: SHF Holdings Faces Nasdaq Delisting, Stock Dilution
Current Report (Form 8-K)
SHF Holdings announced its common stock and warrants will be delisted from Nasdaq, with trading suspended November 18, 2026, while also detailing significant stock conversions.
Summary
- SHF Holdings, Inc. received a notice from Nasdaq indicating its common stock and warrants will be delisted, with trading suspension effective November 18, 2026.
- The company was previously granted an extension until April 19, 2027, to regain compliance with the minimum bid price requirement of $1.00 per share.
- However, a recent ten-day period of closing bid prices at $0.10 or less triggered the delisting.
- The company is considering options, including requesting a hearing before the Nasdaq Hearings Panel and potentially executing a reverse stock split.
- In parallel, the company has seen substantial conversion of Series B Convertible Preferred Stock into common stock, issuing 63,247,931 shares of common stock upon conversion of 7,730 shares of Series B Preferred Stock between October 30, 2026, and November 11, 2026, at a conversion price of $0.1210 per share.
- This conversion led to an increase in outstanding common stock to 148,760,916 as of November 11, 2026.
- The company intends to file an additional registration statement by November 13, 2026, related to the Series B Preferred Stock, with an effectiveness deadline extended to February 11, 2027.
- Despite these challenges, the company intends to complete its proposed business combination with Opifex Media Inc.
Sentiment
Score: 2
Explanation: StockSavvy.ai views this as a negative development due to the impending delisting from Nasdaq and the significant dilution from recent stock conversions, despite ongoing efforts to address these issues.
Positives
- The company intends to complete its proposed business combination with Opifex Media Inc.
- The company is actively considering options to regain compliance with Nasdaq listing requirements, including a potential hearing and reverse stock split.
- A waiver was obtained to extend the filing deadline for an additional registration statement and the effectiveness deadline, avoiding immediate penalties.
Negatives
- The company's common stock and warrants are set to be delisted from The Nasdaq Stock Market LLC, with trading suspended on November 18, 2026.
- The company's common stock has had a closing bid price of $0.10 or less for ten consecutive trading days.
- Significant dilution has occurred due to the conversion of Series B Preferred Stock into 63,247,931 shares of common stock between October 30, 2026, and November 11, 2026.
- The total number of outstanding common shares has increased substantially to 148,760,916 as of November 11, 2026.
Risks
- Delisting from Nasdaq could significantly reduce liquidity and investor interest, potentially impacting the share price.
- Failure to regain compliance with Nasdaq's minimum bid price requirement could lead to permanent delisting.
- The substantial increase in outstanding shares due to preferred stock conversions represents significant dilution for existing common stockholders.
- There is no assurance that an appeal of the delisting determination will be successful or that compliance with listing requirements can be achieved.
- Securities may be quoted on an over-the-counter market after delisting, but there is no guarantee of an active trading market.
- The proposed business combination with Opifex Media Inc. may not be completed.
Future Outlook
The company intends to file an additional registration statement by November 13, 2026, and use commercially reasonable efforts to have it declared effective by the SEC as soon as practicable. The company is considering all available options to regain compliance with Nasdaq's listing requirements, including requesting a hearing and potentially effecting a reverse stock split. The company also intends to complete its proposed business combination with Opifex Media Inc.
Management Comments
- The Company intends to file the Additional Registration Statement on or before November 13, 2026, and the Company will use its good faith, commercially reasonable efforts to cause the Additional Registration Statement to be declared effective by the SEC as soon as practicable after the Additional Registration Statement is filed.
- The Company is considering all available options, including requesting a hearing before the Panel and presenting a plan to regain compliance with the Minimum Bid Price Requirement that includes a commitment to effect a reverse stock split, if necessary.
- Notwithstanding the delisting of the Companys securities from Nasdaq, it remains the intention of the Company to complete its previously announced proposed business combination (the Proposed Transaction) with Opifex Media Inc. (Opifex).
Industry Context
StockSavvy.ai notes that delisting from a major exchange like Nasdaq is a severe blow to a company's visibility and access to capital. This often leads to reduced trading volume and can make it difficult to attract institutional investors. The significant dilution from preferred stock conversions also signals potential financial distress or a strategy to meet immediate obligations at the cost of existing shareholders.
Comparison to Industry Standards
- Companies typically aim to maintain listing on major exchanges like Nasdaq to ensure liquidity and investor confidence. Delisting is a significant negative event.
- A minimum bid price of $1.00 is a standard Nasdaq requirement. Failure to meet this threshold for a sustained period, as seen with SHF Holdings' $0.10 or less closing bid price, is a common trigger for delisting procedures.
- Significant dilution from preferred stock conversions, especially at low conversion prices, is often a sign of a company struggling to raise capital through traditional means or facing covenant breaches.
- Competitors in similar sectors typically focus on growth and profitability to maintain or improve their stock price and listing status, rather than facing delisting.
Stakeholder Impact
- Shareholders: Face significant dilution from preferred stock conversions and potential loss of liquidity and market access due to delisting from Nasdaq. The value of their holdings may be negatively impacted.
- Creditors: May face increased risk if the company's ability to access capital markets is severely hampered by delisting.
- Employees: May experience reduced morale and job security concerns due to the company's precarious financial and listing status.
- Warrant Holders: Their warrants are subject to delisting as the underlying security is also being delisted.
Next Steps
- File the Additional Registration Statement on or before November 13, 2026.
- Use commercially reasonable efforts to have the Additional Registration Statement declared effective by the SEC.
- Consider requesting a hearing before the Nasdaq Hearings Panel to appeal the delisting determination.
- Present a plan to regain compliance with the Minimum Bid Price Requirement, potentially including a reverse stock split.
- Complete the proposed business combination with Opifex Media Inc.
Key Dates
| Date | Description |
|---|---|
| 2025-09-30 | Company entered into Securities Purchase Agreement and Registration Rights Agreement. |
| 2025-10-03 | Filing of Certificate of Designations, Purchase Agreement, and Registration Rights Agreement as exhibits. |
| 2026-04-15 | Company's Annual Report on Form 10-K filed. |
| 2026-05-08 | Company's proxy statement for its 2026 annual meeting filed. |
| 2026-10-19 | Expiration of initial 180-day period granted by Nasdaq to regain compliance with minimum bid price. |
| 2026-10-20 | Company received a letter from Nasdaq regarding eligibility for an additional 180-day period to regain compliance. |
| 2026-10-22 | Conversion price of Series B Preferred Stock was reduced. |
| 2026-10-28 | Start of ten consecutive trading days with closing bid price of $0.10 or less. |
| 2026-10-30 | Company disclosed 85,512,985 shares of Common Stock issued and outstanding. |
| 2026-11-05 | Date of Report (Earliest event reported). |
| 2026-11-06 | Original Filing Deadline for the Additional Registration Statement. |
| 2026-11-10 | End of ten consecutive trading days with closing bid price of $0.10 or less. |
| 2026-11-11 | Company received the November Letter from Nasdaq Staff regarding delisting; 63,247,931 shares of Common Stock issued upon conversion of Series B Preferred Stock. |
| 2026-11-13 | Extended Filing Deadline for the Additional Registration Statement. |
| 2026-11-18 | Suspension of trading of the Company's securities on Nasdaq. |
| 2027-02-11 | Extended Effectiveness Deadline for the Additional Registration Statement (standard). |
| 2027-03-13 | Extended Effectiveness Deadline for the Additional Registration Statement (if subject to full SEC review). |
| 2027-04-19 | Deadline for the Company to regain compliance with Nasdaq's minimum bid price requirement. |
Recommendation
sellThe impending delisting from Nasdaq, coupled with significant share dilution and a prolonged period of extremely low stock prices, presents substantial risks. While the company intends to pursue a business combination and explore options to regain listing compliance, the immediate challenges are severe and likely to negatively impact the stock price further. Investors should consider selling to avoid potential further losses associated with delisting and dilution.
Keywords
delisting, Nasdaq, preferred stock conversion, registration statement, business combination, minimum bid price, equity securities, stock warrants
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.